◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Parkinson Disease
Sponsor Massachusetts General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2020-10-01
Completion 2027-02
All Conditions
Interventions
electrophysiological data collection
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this research study the researchers want to learn more about brain activity related to speech perception and production.
Eligibility Criteria
Inclusion Criteria: 1. Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease, essential tremor or dystonia. 2. Subjects able to provide informed consent and comply with task instructions. 3. Subjects 18-85 years old Exclusion Criteria: 1. Subjects with reported hearing loss. 2. Non-English-speaking subjects
Related Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology